YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Spiking Treasury yields have pushed many investors back toward safer assets, which has punished weaker balance sheets and rewarded stronger ones. That creates an opening for you. Solid, low priced companies that already showed gains over t…
Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index adding 0.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Jim Cramer openly shares his opinions about various stocks, and on September 3, 2026, during an episode of CNBC's Mad Money, he gave his two cents on Nuvation Bio (NUVB). A caller asked about the surging biopharma name, and Cramer answered…
[Patients Receiving Medical Infusions in a Clinical Setting with Nurse Assistance] FatCamera/iStock via Getty Images Earlier this week, shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and partner Merck (MRK [https://seeking…
[Wall Street sign in Lower Manhattan, NYC] georgeclerk * Nuvation Bio (NUVB [https://seekingalpha.com/symbol/NUVB]) is trading 2% higher Friday morning after Cantor Fitzgerald initiated the stock at overweight, saying that the Street is un…
It's not often that a small drug company convinces Wall Street's big banks that its stock could double. Nuvation Bio (NUVB) just got that call. On Tuesday, Aug. 18, 2026, JPMorgan started covering the stock with an Overweight rating, which…
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President of Corporate Development and Investor Relations - Robert DeVitaFounder, President and Chief Executive Officer - David HungChief Commer…
Key Points Interested in Nuvation Bio Inc.? Here are five stocks we like better. IBTROZI momentum strengthened: Second-quarter revenue reached $31.7 million, including $23.2 million in U.S. product revenue, up 25% sequentially. About 85% o…
The second-quarter 2026 earnings season is currently in full swing. The scorecard for the Medical sector is pretty good so far. The sector primarily comprises pharma/biotech and medical device companies. The earnings season for the pharma/…
Nuvation Bio Inc. (NYSE:NUVB) is one of the best small cap stocks to buy with the highest upside potential. RBC Capital lowered the price target on Nuvation Bio Inc. (NYSE:NUVB) to $19 from $20 on July 7 and reaffirmed an Outperform rating…
Nuvation Bio Inc (NYSE:NUVB) is one of billionaire David Abrams' top stock picks with upside potential. Nuvation Bio shares gained nearly 170% over the past year, and analysts project a more than 150% upside for the stock over the next 12…
In late June 2026, Nuvation Bio announced that partner Eisai's Marketing Authorisation Application for taletrectinib in advanced ROS1-positive non-small cell lung cancer was validated by the U.K. MHRA under the International Recognition Pr…
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. From a headline-generating $14 billion deal with Pfizer for his startup Medivation to his new compa…
On June 23, 2026, Stacy Markel, Chief People Officer at Nuvation Bio Inc. (NYSE:NUVB), exercised 125,000 options for Class A Common Stock and sold the resulting shares for a transaction value of approximately $753,000, according to the SEC…
Key Points According to a Form 4 filing, a Nuvation Bio executive reported selling 125,000 Class A shares for a total value of $753,000 on June 23, 2026. This transaction represented 79.32% of Markel Stacy’s direct Class A holdings, reduci…
Gilead Sciences (GILD) shares rallied 3.3% in the last trading session to close at $127.88. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's…
(RTTNews) - Nuvation Bio Inc. (NUVB), an oncology company, priced an upsized offering of $250 million aggregate principal amount of 0.75% convertible senior notes due in 2032. The aggregate principal amount was increased from the previousl…
* Global oncology company Nuvation Bio (NUVB [https://seekingalpha.com/symbol/NUVB]) announced Friday the pricing of an upsized underwritten offering of $250M aggregate principal amount of 0.75% Convertible Senior Notes due 2032. * The agg…
Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains. On June 9, 2026, Director Robert Mashal reported the acquisition of 25,000 shares of Nuvation Bio…
Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Penny Stocks That Could Skyrocket in 2026. On June 9, Reuters reported that GSK agreed to acquire cancer drug developer Nuvalent for a deal worth $10.6 billion. On the same day, RBC Capital…
Over the last 7 days, the United States market has dropped 3.3%, though it has risen by 22% over the past year, with earnings forecasted to grow annually by 17%. In light of these conditions, identifying stocks with robust financials and c…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Nuvation Bio (NYSE:NUVB) has completed a technology transfer partne…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Thermo Fisher Scientific (NYSE:TMO) has completed technology transf…
Omega Fund Management disclosed a buy of 187,500 shares of Bicara Therapeutics(NASDAQ:BCAX) in a May 15, 2026, SEC filing, with the estimated transaction value at $3.23 million based on quarterly average pricing. What happened According to…
On May 15, 2026, Omega Fund Management disclosed in an SEC filing that it sold 411,968 shares of Alumis(NASDAQ:ALMS), with the estimated transaction value at $10.3 million based on quarterly average pricing. What happened According to its…
Omega Fund Management cut its stake in Kestra Medical Technologies (NASDAQ:KMTS), selling 351,442 shares in the first quarter for an estimated $8.28 million based on quarterly average pricing, according to a May 15, 2026, SEC filing. What…
Investor Stanley Druckenmiller’s Duquesne Family Office exited a 385,000 share position in Alphabet in the first quarter. Continue Reading
Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States Move by Nuvation Bio further ensures critical drug supply for patients and providers NEW YORK, May 13, 2…
(RTTNews) - Wednesday, Nuvation Bio Inc. (NUVB) announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application with updated data for IBTROZI for the treatment of advanced ROS1-positive non-small cell…
Earnings Call Insights: Nuvation Bio (NUVB) Q1 2026 MANAGEMENT VIEW * Dr. David Hung said the launch is being driven by steady demand and an improving mix toward earlier-line use: “We successfully treated approximately 200 new patients wit…
Nuvation Bio Inc. Q1 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Performance in Q1 was characterized by a significant shift in patient mix, with TKI-naive (first-line) patients exceeding 50% of new starts for…
Achieved $18.5 million in first quarter of 2026 net product revenues for IBTROZI® (taletrectinib); majority of the approximately 200 patients started on IBTROZI in the first quarter of 2026 were TKI-naïve, highlighting continued momentum i…
The market expects CRISPR Therapeutics AG (CRSP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing th…
Nuvation Bio, Inc. (NYSE:NUVB) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock’s price more than doubled from a year ago, up 156.7%, while it registered a 40.79% increase year-to-date. On April 16, Wedbus…
Nuvation Bio Inc (NYSE:NUVB) is among the must-buy penny stocks to invest in now. RBC Capital analysts see bright prospects for Nuvation Bio Inc (NYSE:NUVB) in the glioma treatment market, which they say is underserved. On April 6, RBC Cap…
In this article, we will look at the 5 Best Small-Cap Biotech Stocks According to Hedge Funds. Please visit 10 Best Small-Cap Biotech Stocks According to Hedge Funds if you’d like to see an extended list and methodology behind it. 5. Nuvat…